Ir para o conteúdo

The Evidence Base

@theevidencebase.bsky.social did:plc:pb4wpto3rgocga55xxqs6ecg

Providing the latest news, opinion and insight into hot topics including real-world data, health economics and outcomes research and patient-centric care.

No Bluesky desde

Seguidores
119
Seguindo
72
Posts
608
Dias nos rankings
0

Resumo

The Evidence Base (@theevidencebase.bsky.social) é um usuário do Bluesky desde 6 dezembro 2024. Tem 119 seguidores, segue 72 contas e publicou 608 posts.

Aparições nos rankings

Os melhores dias em que posts desta conta entraram na lista diária do Debya.

Esta conta ainda não apareceu em um ranking diário.

Posts curtidos recentemente

Curtidas públicas da rede Bluesky.

  • Journal of Comparative Effectiveness Research@journal-cer.bsky.social

    📢New article alert Treatment burden and healthcare resource utilization in patients with chronic rhinosinusitis with nasal polyps who did or did not undergo functional endoscopic sinus surgery: a US real-world retrospective cohort study 🔗 becarispublishing.com/doi/10.57264... #OpenAccess #JCER

    Ver post
  • Journal of Comparative Effectiveness Research@journal-cer.bsky.social

    📢New article alert New Perspective article on "Sieving for gold: external comparator studies to prioritize drugs for late-stage clinical trial" 🔗Read here: becarispublishing.com/doi/10.57264... #OpenAccess #JCER #TrialMethodology #RealWorldEvidence #RWE

    Ver post
  • Journal of Comparative Effectiveness Research@journal-cer.bsky.social

    📢New article alert New Research Article on “Indirect comparisons of tucatinib in combination with trastuzumab for patients with previously treated HER2–positive metastatic colorectal cancer”. 🔗Read here: becarispublishing.com/doi/10.57264... #OpenAccess #JCER #ColorectalCancer #Oncology #ITC

    Ver post
  • Journal of Comparative Effectiveness Research@journal-cer.bsky.social

    📢New Research Article alert "Acthar Gel versus standard of care for adults with proteinuria in nephrotic syndrome due to focal segmental glomerulosclerosis: cost-per-response analysis from the US healthcare perspective" 🔗 becarispublishing.com/doi/10.57264... #OpenAccess #JCER #KidneyDisease

    Ver post
  • Journal of Comparative Effectiveness Research@journal-cer.bsky.social

    📢New article alert New Short Report on "First-line tumor necrosis factor inhibitor versus abatacept treatment choice in real-world patients with anticitrullinated protein antibody- and rheumatoid factor-positive rheumatoid arthritis". 🔗Read here: becarispublishing.com/doi/10.57264... #OpenAccess

    Ver post

Entre para ver mais

Contas que bloqueia

No Bluesky, bloqueios são registros públicos.

Esta conta não bloqueia ninguém.